⌘K
t
BioPharma Credit plc announced on 9 May 2025 that its Annual General Meeting (AGM) will be held at 1.00 p.m. on 9 June 2025. The meeting will take place at the offices of Herbert Smith Freehills LLP in London, following the publication of its Annual Financial Report for the year ended 31 December 2024 on 25 March 2025.
| Date | 9 May 2025 |
| Time | 16:34:58 |
| Category | AGMs and other meetings |
| ID | 1414I |
9 May 2025
BioPharma Credit plc
(the "Company")
NOTICE OF ANNUAL GENERAL MEETING
Following the publication on 25 March 2025 of its Annual Financial Report for the year ended 31 December 2024, the Company announces that it will hold its Annual General Meeting ("AGM") at 1.00 p.m. on 9 June 2025 at the offices of Herbert Smith Freehills LLP, Exchange House, Primrose Street, London EC2A 2EG.
A copy of the Notice of the AGM is available to view on the Company's website at http://www.bpcruk.com. It has also been submitted to the National Storage Mechanism and is available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism. Copies of the Notice of the AGM have been posted or made available to the Company's Shareholders.
Enquiries:
BioPharma Credit plc
via MUFG Corporate Governance Limited
Company Secretary
+44 (0) 333 300 1932
Burson Buchanan
Mark Court / Jamie Hooper / Henry Wilson / Samuel Adams
+44 (0)20 7466 5000
biopharmacredit@buchanan.uk.com
Notes to Editors:
BioPharma Credit PLC is London's only listed specialist investor in debt from the life sciences industry and joined the LSE on 27 March 2017. The Company seeks to provide long-term shareholder returns, principally in the form of sustainable income distributions from exposure to the life sciences industry. The Company seeks to achieve this objective primarily through investments in debt assets secured by royalties or other cash flows derived from the sales of approved life sciences products.
LEI: 213800AV55PYXAS7SY24